Ordering Recommendation

Use to screen for alpha-2-antiplasmin deficiency. Not a first-line test for diagnosing inherited thrombotic or bleeding disorders.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Lt. blue (sodium citrate). Refer to Specimen Handling at aruplab.com for hemostasis/thrombosis specimen handling guidelines.

Specimen Preparation

Transfer 1 mL platelet-poor plasma to an ARUP standard transport tube. (Min: 0.5 mL)

Storage/Transport Temperature

CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.

Unacceptable Conditions

Serum. EDTA plasma, clotted or hemolyzed specimens.

Remarks
Stability

mbient: 4 hours; Refrigerated: Unacceptable; Frozen: at -20° C: 3 months; at -70° C: 6 months

Methodology

Chromogenic Assay

Performed

Thu

Reported

1-8 days

Reference Interval

By Report

Age Activity (%)
1-4 days 55-115%
5-29 days 70-130%
30-89 76-124%
90-179 days 76-140%
180-364 days 83-139%
1-5 years 93-117%
6 years 89-110%
7-9 years 88-147%
10-11 years 90-144%
12-13 years 87-142%
14-15 years 83-136%
16-17 years 77-134%
18 years and older 82-133%

Interpretive Data



Compliance Category

FDA

Note

Hotline History

N/A

CPT Codes

85410

Components

Component Test Code* Component Chart Name LOINC
0098727 Alpha-2 Antiplasmin Activity 27810-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • a2-Antiplasmin
  • Alpha 2 Antiplasmin
  • Alpha-2 Proteinase Inhibitor
  • Antiplasmin, Activity, Plasma
  • Antiplasmin, Functional, Plasma
  • Functional Antiplasmin
  • Plasmin Inhibitor
Alpha-2-Antiplasmin, Activity